Scientists re-engineer Patients' own cells to hunt down blood cancers

This is an early-stage safety study testing a new type of cell therapy for adults with certain recurring B-cell blood cancers (like lymphoma, myeloma, or CLL) that have not responded to standard treatments. Doctors take a patient's own immune cells (T cells), genetically modify them in a lab to better recognize and attack cancer cells, and then infuse them back into the patient. The main goal is to see if this approach is safe and to find the best dose, while also checking for any early signs that it might help control the cancer.